4th International 4 Corners of Cardiology Meeting
The 4 Corners of Cardiology Meeting Organising Committee are pleased to announce the following invited speakers:
Prof Craig Anderson
Dr Anderson is Professor of Medicine, University of New South Wales; Executive Director, The George Institute China; Senior Director, Stroke Research, Neurological and Mental Health Division, The George Institute for Global Health, Australia; neurologist at Royal Prince Alfred Hospital; and Senior Principal Research Fellow of the National Health and Medical Research (NHMRC) of Australia.
He has published on the clinical and epidemiological aspects of stroke and cardiovascular disease, and has led several large-scale epidemiological projects and multi-centre clinical trials, the results of which have influenced clinical practice guidelines for the treatment of acute stroke and prevention of cardiovascular disease.
Prof Derek Chew
Clinical and Interventional Cardiologost
Flinders Medical Centre, Adelaide, Australia
My clinical and research career has been focused on the translation of current and further therapies and technologies in cardiology into improved patient outcomes. My current appointment is as the Heart Foundation Edwards Senior Research Fellow, at Flinders University, with contribution to the cardiovascular clinical service at Flinders Medical Centre. I am the Clinical Director of the Cardiovascular Outcomes Research group at the Flinders Medical Centre and the Regional Director of Cardiology Southern Adelaide Health Service. My initial contributions have been in the role of novel anti-thrombotic approaches to the treatment of coronary heart disease, specifically highlighting important aspects of clinical trials which provide opportunities for optimization of current therapeutic approaches or where added benefits may be gained among high-risk individuals. After completing a Masters of Public Health at the Harvard School of Public health, my more recent directions have focused on the deficits in the provision of care in Acute Coronary Syndromes, recently completing the largest ever registry solely conducted in Australia, directed towards the evaluation of adherence to guidelines, evaluation of local outcomes and definition of underserved groups. I am the current Clinical Steward of ACS-Data, the national standardised definitions for data elements in acute coronary syndrome management held by the Australian Institute of Health and Welfare. In partnership with the National Heart Foundation (NHF), I am developing an electronic decision support tool for the initial management of patients presenting with acute coronary syndromes, which will be provided free of charge to all hospitals in Australia. In addition I serve on the NHF acute coronary syndrome guideline implementation working group and the Clinical Issues Committee. I have published over 100 original articles and 12 book chapters have regular international invitations to speak on the application of anti-thrombotic therapies and other evidence based therapies in acute coronary syndrome management.
Prof Andrew Coats
Lone Star Heart Inc.
Andrew, DM (Oxon), DSc. (Imperial), MBA, born in Australia and a graduate of Oxford and Cambridge, was Viscount Royston Professor at Imperial College, Director of Cardiology at Royal Brompton Hospital, Dean of Medicine and DVC at Sydney and CEO of the Norwich Research Park. He is director of the Monash Warwick Alliance. Andrew has 57,000 citations (H-index 107) in the field of heart failure research and has led many major clinical trials. Andrew received the Linacre Medal (Royal College of Physicians) and Michael L Pollock award (American Heart Association). Andrew co-founded PsiOxus therapeutics and served as editor-in-Chief of the International Journal of Cardiology 1999-2016.
Prof Louise Cullen
Senior Staff Specialist
Royal Brisbane and Women’s Hospital, Brisbane, Australia
Prof Louise Cullen is currently a Senior Staff Specialist in the Department of Emergency Medicine, Royal Brisbane and Women’s Hospital, and an active clinician-researcher with particular interests in acute cardiac diseases, syncope, and cardiac biomarkers. She is widely published in numerous peer-reviewed journal including the Lancet. Her mantra is that “you do not do research for research sake” and as such, clinical redesign and translational research is a key part of her endeavours.
Dr Carmine De Pasquale
Dr De Pasquale worked in Critical Care prior to completing his physician training specialising in Cardiology in 2000. He then completed his PhD in 2003 studying the effects of heart failure on the lungs. In 2003 he undertook a Clinical Fellowship in Heart Failure at the St Vincent’s Hospital, Sydney. Dr De Pasquale has expertise in heart failure and echocardiography. He is also a Senior Lecturer at the Flinders University where he has ongoing research interests in heart failure both at the laboratory scientific level and clinical therapeutics level. While his animal based research involves exploration of the mechanisms of evolution of the heart failure syndrome, his clinical research involves in international treatment trials of novel heart failure therapeutics. He has won research funding through competitive national grants and his research has been recognised with international journal scientific publications. Dr De Pasquale was the president of the Cardiac Society of Australia and New Zealand Heart Failure Council in 2007-8, he took over as the chair of the South Australian Heart Failure Network working group in 2011.
Dr Mike Farkouh
MICHAEL E. FARKOUH, MD, FRCPC, MSc, FACC, FAHA – is the Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, Director of the Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research, Professor and Vice-Chair, Research, Department of Medicine at the University of Toronto. He is a graduate of the Schulich School of Medicine at Western University. Dr. Farkouh completed his internal medicine and cardiology training at the Mayo Clinic and the Icahn School of Medicine at Mount Sinai New York respectively and holds an MSc in Clinical Epidemiology from McMaster University. He is currently the leader for numerous clinical trials on questions related to diabetes and heart disease including the NIH-sponsored FREEDOM and TAILOR-PCI trial. Dr. Farkouh serves as Associate Editor of the Journal of the American College of Cardiology.
Prof John French
Professor John French is an academic interventional cardiologist, having co-authored 215 peer-reviewed papers. Prof French currently works at Liverpool Hospital, Wagga Wagga Base Hospital, and also consults at Riverina Cardiology and South West Cardiology (in Camden), NSW, Australia. His major clinical and research interests include management of acute coronary syndromes especially ST elevation MI with acute percutaneous coronary intervention (PCI), cardiac biomarkers especially high sensitivity troponins, and revascularisation of patients with diabetes; while no longer having a laboratory Prof French has an ongoing interest in cardiac genetics. Prof French has been a conjoint Professor at UNSW since 2003, director of Cardiac Research at Liverpool Hospital since 2004, and director of the Coronary Care Unit in the Cardiology Department at Liverpool Hospital (HOD 2007-11). Prof French has recently co-authored the NHF-CSANZ (Cardiac Society of Australia and New Zealand) 2016 ACS guidelines (lead writer for the STEMI section). He was the medical co-chair of the ACI cardiac network of NSW [2012-5], and chair of the clinical trials council of CSANZ [2011-4].
A/Prof Anand Ganesan
Associate Professor Anand Ganesan is a Matthew Flinders Fellow in Cardiology. He undertook his MBBS at the University of Sydney(2000), PhD at Johns Hopkins University (2006), FRACP (cardiology) at Westmead Hospital (2010), and Postdoctoral Fellowship at the University of Adelaide (2011-2014). He is practising cardiologist and cardiac electrophysiologist, with research interests in the development and application of novel cardiovascular technologies in the area of atrial fibrillation mapping and mobile health.
A/Prof Christian Hamilton Craig
A/Prof Christian Hamilton-Craig is Eminent Staff Cardiologist at the Prince Charles Hospital with academic appointment at the Centre for Advanced Imaging, University of Queensland, Brisbane Australia. He specializes in cardiovascular imaging (Echo, CT, MRI). He is co-chair of the CSANZ working group who recently published the 2017 CSANZ Position Statement on Coronary Artery Calcium Scoring. He is currently chair of the ANZ branch Society of Cardiovascular Computed Tomography (SCCT), and the President of the ANZ Cardiovascular Magnetic Resonance working group (ANZCMR).
Dr Marcus Ilton
Photo and Bio to come…
Prof Peter Kistler
Professor Kistler is the Head of Clinical Electrophysiology Research at The Baker IDI Heart and Diabetes Institute and Head of Electrophysiology at The Alfred hospital. He is Professor of Medicine at the University of Melbourne and currently supported by a federally funded National Health and Medical Research Council (NHMRC) Practitioners fellowship. He has completed a PhD in atrial fibrillation mechanisms and post doctoral research at St Bartholomews Hospital, London. He has more than 120 publications many in the world’s leading cardiology journals. His expertise is in the management of patients with arrhythmias which encompasses diagnosis, medical therapy, electrophysiology study and catheter ablation and device therapy including pacemakers, defibrillators and cardiac resynchronization therapies. He has a particular interest in catheter ablation of complex arrhythmias such as atrial fibrillation.
Dr Geoff Lee
Dr Geoff Lee is a Cardiologist and Electrophysiologist with a joint appointment in the Department of Cardiology at Melbourne Health and the Department of Medicine at the University of Melbourne. He specializes in complex mapping and AF and VT ablation. He has received several prestigious awards including the National Health and Medical Research Council (NHMRC) Gustav Nossal Postgraduate Scholarship for the highest ranked applicant from the combined medical and dental post graduate research scholarships (2011) and has a Neil-Hamilton Fairely Early Career Fellowship (2012-2016). His current research focuses on 3D mapping and visualization of persistent atrial fibrillation. He is also responsible for the clinical supervision and training of cardiology registrars, cardiology fellows and PhD candidates.
Dr Dominik Linz
University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
Dominik graduated from the University of Mainz, Germany, in 2007. He joined the world-renowned translational cardiovascular research institute (CARIM) in Maastricht, The Netherlands, and obtained his PhD in 2013. After completing a Cardiology training at the University Hospital in Homburg/Saar, Germany, Dominik moved to South Australia to join the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide in 2017. To date, Dominik has co-authored more than 80 peer-reviewed publications. As a clinician scientist dedicated to combine preclinical studies and clinical research, he focuses on risk factors management and autonomic modulation in the field of atrial fibrillation.
Dr Sidney Lo
Graduated with honours from the University of Sydney 1988 and internship at Royal Prince Alfred Hospital in Sydney.
Cardiology training 1994 and 1995 at Alfred Hospital in Melbourne and 1996 Senior Cardiology Registrar 1996-1997 Royal North Shore Hospital.
Interventional Fellowship Stanford University Medical Centre 1997-1998, and then on staff till returning to Australia to Liverpool Hospital in 2000.
Research interests include ACS, Direct oral anticoagulants, novel stenting, complex PCI, intracoronary imaging and cardiogenic shock and cardiac support devices. Director of Cardiac Catheterisation Laboratories and senior cardiologist at Liverpool Hospital, secretary to interventional Council of CSANZ, co convener EPIC since 2006, co-convener ANZCTO and course Director ANZCCT and organising committee for ANZET.
Prof Richard O'Brien
Professor Richard O’Brien is Clinical Dean of the University of Melbourne Clinical School, Austin Health, where he is also Director of the Lipid Service and a senior endocrinologist. Prof O’Brien is president-elect of the Asia Pacific Society of Atherosclerosis and Vascular Diseases and he currently chairs the Australian Diabetes Society expert committee on hyperlipidaemia. His research interests focus on atherosclerosis, diabetes and lipid abnormalities. In addition to his teaching and research commitments, Prof O’Brien maintains active clinical practice in Endocrinology and Diabetes.
Dr Milton Packer
Milton Packer, MD, is an internationally recognized clinical investigator who has made many seminal contributions to the field of heart failure, both in understanding its mechanisms and defining its rational management. Dr. Packer’s work has spanned nearly 40 years and has been strongly supported by numerous investigator-initiated grants from the NIH and from industry. His research established the cornerstone of the current modern treatments for heart failure, for which he was the recipient of the Lewis Katz lifetime achievement award in cardiovascular research. Dr. Packer has served frequently as a member of government advisory committees, study sections, task forces or Data and Safety Monitoring Boards for the NIH. Dr. Packer was President of the Heart Failure Society of America from 2000-2002 and has served on numerous guidelines and standards committees for the American Heart Association and American College of Cardiology. Dr. Packer is currently the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center.
Dr Mark Perrin
Dr Mark Perrin is a cardiac electrophysiologist with appointments at the University Hospital Geelong and the Royal Melbourne Hospital. He completed his MBBS at the University of New South Wales and FRACP at St Vincent’s Hospital in Sydney. He undertook a PhD in drug-induced arrhythmia at the Victor Chang Cardiac Institute (UNSW) before pursuing postdoctoral studies and a clinical arrhythmia fellowship at the University of Ottawa, Canada. He has a special interest in genetic arrhythmia syndromes and the management of atrial fibrillation.
A/Prof Julie Redfern
Deputy Director of the Cardiovascular Division
The George Institute for Global Health
A/Professor Julie Redfern is Deputy Director of the Cardiovascular Division at The George Institute for Global Health, Postgraduate Coordinator at Sydney Medical School at the University of Sydney and co-Chair of the Exercise, Prevention and Rehabilitation Council of the CSANZ and a practicing physiotherapist. Julie holds a NHMRC Career Development and Heart Foundation Future Leader Fellowship. She was recently selected on the World Heart Federation Emerging Leader Program and concluded a 6 year term on the CSANZ Board and as Chair of the Allied Health Council. Julie’s research aims to improve access to and engagement with secondary prevention strategies.
Prof Christopher Reid
Professor Christopher Reid is a cardiovascular epidemiologist and holds positions as Associate Director of the Monash Centre of Cardiovascular Research and Education in Therapeutics at Monash University and Research Professor at Curtin University. He holds a National Health and Medical Research Council Senior Research Fellowship in addition to being a Chief Investigator on both NHMRC Project and Program Grants focusing on cardiovascular disease prevention. His major research interests include clinical outcome registries, randomised trials, and epidemiological studies. He has been Study Director for the 2nd Australian National Blood Pressure (ANBP2) Study and currently a Chief Investigator for the Aspirin in Reducing Events in the Elderly (ASPREE) Study and the Australian arms of the HOPE-3, REACH and CLARIFY Registries. He is a Principal Investigator for the Victorian Cardiac Procedures Registry Project and the Melbourne Interventional Group (MIG) registries. He has more than 300 publications including over 260 peer reviewed journal articles, many of which are in leading journals including the New England Journal of Medicine, Lancet, JAMA and the BMJ. He Chairs the Steering Committee of the Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) Collaboration and participates as a WHO consultant for prevention of cardiovascular disease in Mongolia, Vietnam and the West Pacific region.
Prof Frank Ruschitzka
Professor Frank Ruschitzka, MD, FRCP (Edinburgh), FESC is co-head of the Department of Cardiology at the University Hospital in Zürich, Switzerland. Professor Ruschitzka received his medical degree from the University of Göttingen in Germany in 1989. He specialized in internal medicine, nephrology and cardiology at the Universities of Göttingen and Zürich.
In 2001, he received the Cardiovascular Science Award of the Swiss Society of Cardiology as well as the Annual Award of the Swiss Society of Hypertension. In 2003, he was awarded the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research.
In September 2016 Professor Ruschitzka received the Honoris Causa Doctorate of the University of Medicine and Pharmacy “Carol Davila” Bucharest.
Professor Ruschitzka is President of the Heart Failure Association of the European Society of Cardiology and deputy editor of the European Heart Journal. Professor Ruschitzka has published in such peer-reviewed journals as the New England Journal of Medicine, The Lancet, Proceedings of the National Academy of Sciences, European Heart Journal, Circulation, and Journal of the American College of Cardiology.
Professor Ruschitzka’s team focusses on translational research, from the development of novel drugs and devices to randomized clinical trials, in coronary artery disease and heart failure in particular.
Dr Greg Starmer
Director of Cardiology, Cairns Base Hospital, Cairns, Australia
Dr Greg Starmer is a Clinical and Interventional Cardiologist, and is the current Director of Cardiology at the Cairns Hospital in Far North Queensland.
His professional interests include complex coronary intervention including rotational atherectomy, structural heart intervention, and the ongoing refinement of systems of care and cardiac outreach services in the Far North. He is also the current Chair of the interventional steering committee of the Queensland Cardiac Outcomes Registry.
Prof Liza Thomas
Liza Thomas is a Conjoint Professor at the University of Sydney and University of New South Wales and is head of the noninvasive cardiac imaging in the Department of Cardiology at Westmead Hospital. Her major research focuses on echocardiography and noninvasive cardiac imaging. Specific interests include imaging for the assessment of atrial dynamics and function, diastolic function, chemotherapy induced cardiomyopathy, amyloid and Fabry cardiomyopathies and cardiac involvement in chronic kidney disease. She is the cardiovascular coordinator for the NSW Fabry and Amyloidosis groups. Prof Thomas supervises PhD, Masters and ILP students. She has been an invited speaker at national and international meetings.
Prof Gerald Watts
Royal Perth Hospital Unit, University of Western Australia, Perth, Australia
Gerald F Watts is a senior consultant physician, university professor and chair of The Familial Hypercholesterolaemia-Australasia Network. He trained at Imperial and King’s Colleges in the University of London before moving to Australia. He is currently director of the Metabolic Research Centre, Cardiometabolic Services (Department of Cardiology) and Head of the School of Medicine and Pharmacology Unit (University of Western Australia) and Professor of Cardiometabolic Medicine at the Royal Perth Hospital campus. Research interests include lipid disorders, obesity and cardiovascular prevention, and clinical interest focuses on delivering improved health care for FH and related conditions. Professor Watts is actively involved in teaching and supervisors several MD and PhD students and post-doctoral fellows. He has authored over 500 published works and is on the editorial board of Atherosclerosis, Clinical Science, Metabolism, Journal of Clinical Lipidology, and Current Opinion in Lipidology.
Dr Michael Wong
Dr Michael Wong obtained his medical degree from the University of Melbourne and completed his Doctoral Fellowship in Cardiac Electrophysiology at the Royal Melbourne Hospital and University of Melbourne describing novel findings on predictors, mechanisms and contemporary epicardial ablation techniques for lethal cardiac arrhythmias and sudden cardiac death. His novel work has received numerous local, national and international Young Investigator Awards including the prestigious Ralph Reader Prize from the Cardiac Society of Australia and New Zealand/World Congress of Cardiology, the Clinical Young Investigator Award from the North American Heart Rhythm Society and the National Heart Foundation Paul Korner Innovation Award. Michael is currently Head of Cardiac Electrophysiology & Devices at Western Health and a National Heart Foundation Postdoctoral Fellowship recipient.
Early Bird Deadline:
8th December 2017
9th – 10th February 2018
Sponsorship Expression of Interest
Expression of Interest
Complete the expression of interest form to receive updated information on the 4 Corners of Cardiology Meeting 2018!
Address for Communications
4CCardiology Meeting Managers
91-97 Islington St
Collingwood VIC 3066
Telephone: +61 2 9265 0700